Jara Llenas-García

20PUBLICATIONS
79CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsAboriginal and Torres Strait Islander medicine and treatmentsDisease surveillanceAnimal growth and developmentBehavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jul 16, 2026
Effect of Non-nucleoside Resistance-Associated Mutations on the Effectiveness of Long-Acting Cabotegravir + Rilpivirine Therapy: Insights From the Real-World RELATIVITY Cohort.

|Apr 21, 2026
Effectiveness and Persistence of Long-Acting Injectable Cabotegravir and Rilpivirine in Migrant Individuals Living With HIV in Spain: Substudy of the RELATIVITY Cohort.

|Mar 09, 2026
Community-Based Screening for HIV and Viral Hepatitis Using Dried Blood Spots in a Migrant Population in Spain: The HEPINMIGRA Study.

Jara Llenas-García, Miriam Navarro, Maria Paz Ventero

|Jan 28, 2026
Clinical and Epidemiological Characteristics of an Oropouche Virus Outbreak in Loreto, Peru (October 2024-March 2025).

Miguel Ángel Rojo-Pérez, Edgar A Ramírez-García, Jara Llenas-García

|Jan 25, 2026
Long-acting cabotegravir and rilpivirine in people with HIV and obesity: Real-world outcomes from the RELATIVITY cohort.

Jesús Troya, Rafael Mican, María José Galindo

|Oct 23, 2025
A prospective assessment of the efficacy and durability of long-acting cabotegravir and rilpivirine in individuals with HIV in Spain (RELATIVITY study).

Luis Buzón-Martín, Maria Luisa Montes, Roberto Pedrero

Pageof 4

Frequent Collaborators

10 joint publications

Philp Wikman-Jorgensen

7 joint publications

José-Manuel Ramos-Rincón

5 joint publications

Miriam Navarro

4 joint publications

Jesús Troya García